In many human cancers including sarcomas, breast and others, p53, a highly connected “node” in its network, is now recognized to be the most frequently inactivated gene due to degradation of p53 stimulated by extra MDM2 genes or mutation in the DNA-binding domain preventing p53 from binding to specific DNA sequences40. The gene discussed is TP53; the disease is sarcoma.